title: Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab.
authors.forename: I
authors.initials: I
authors.lastname: Marie
authors.forename: P
authors.initials: P
authors.lastname: Heliot
authors.forename: F
authors.initials: F
authors.lastname: Roussel
authors.forename: F
authors.initials: F
authors.lastname: Hervé
authors.forename: J F
authors.initials: JF
authors.lastname: Muir
authors.forename: H
authors.initials: H
authors.lastname: Levesque
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D000069285:Infliximab; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000139:chemically induced*; D009894:Opportunistic Infections / Q000139:chemically induced; D018410:Pneumonia, Bacterial / Q000139:chemically induced*; D017285:Polymyositis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab